Breaking News

Nordic Bioproducts Receives EXCiPACT Certification for MCC Production at Lappeenranta Facility

The Finnish company’s new factory has received the certification after being thoroughly audited by a recognized international entity.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Nordic Bioproducts Group announced that its new manufacturing factory in Lappeenranta, Finland, has received the EXCiPACT certification to produce microcrystalline cellulose (MCC). EXCiPACT is an independent, not-for-profit association that provides management oversight for the third-party certification of manufacturers, suppliers, and distributors of pharmaceutical excipients worldwide. EXCiPACT selects independent, third-party accredited certification bodies that employ ISO 9001 qualified ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters